So, You Built A Surgical Robot. How Do You Sell It?
Executive Summary
CMR Surgical has grown rapidly since being founded just over eight years ago. However, unlike most other medtech companies, CMR is not selling a ~$30 diagnostic test, or a ~$5,000 pacemaker. It is selling a complex surgical robot, called Versius, with a price tag rumored to be in the seven figures.
You may also be interested in...
Monarch: Half Out Of Its Cocoon, Ready To Emerge As A J&J Platform
Worldwide president of Johnson and Johnson’s Monarch platform speaks to In Vivo about the group’s potential and its commercial strategy.
CMR Signs Deal With J&J To Bring Robots To Europe And South America
CMR Surgical will collaborate with Johnson & Johnson/Ethicon to expand access to its Versius robotic surgery system.
Exec Chat: ‘It’s More Than Just A Robot’: Versius' Maker Drives New Culture Of Accountability In Surgery
Medtech Insight spoke to Mark Slack, the company’s co-founder, to learn about his vision for transforming surgery, including robotics role in improving surgical training and driving better outcomes for patients.